Stockreport

Anbio Biotechnology: Improved Margins, Still Priced For Growth That Isn't Showing Up [Seeking Alpha]

Anbio Biotechnology - Class A Ordinary Shares  (NNNN) 
PDF In practice, this has improved near-term operating metrics, but their topline has decreased as well, so it's not a major win in the bigger picture. NNNN sells portabl [Read more]